Summary:
The LAVENDER Study is currently open to people who have lupus
that affects their skin – cutaneous lupus erythematosus (CLE)
We are looking for people who:
- Are 18 to 70 years of age (inclusive).
- Have been diagnosed with CLE.
- Have had standard antimalaria medications for CLE which did not
sufficiently improve the condition OR are unable to take antimalarial
medication due to concerns related to possible side effects.
There are other criteria that potential participants will need to meet to join this study; the study team
will discuss these with interested participants.